A New Recombinant Subunit Vaccine against Equine Herpesviruses 1 and 4. Equine herpesviruses 1 and 4 (EHV-1 and EHV-4) cause respiratory disease, abortion and myeloencephalitis in horse populations worldwide. Despite extensive use of whole virus vaccines, these two viruses continue to circulate among Australian horses and are a continuing threat to brading, and to racing performance. The current vaccines are expensive and are marked in Australia by an overseas company. The project will assess th ....A New Recombinant Subunit Vaccine against Equine Herpesviruses 1 and 4. Equine herpesviruses 1 and 4 (EHV-1 and EHV-4) cause respiratory disease, abortion and myeloencephalitis in horse populations worldwide. Despite extensive use of whole virus vaccines, these two viruses continue to circulate among Australian horses and are a continuing threat to brading, and to racing performance. The current vaccines are expensive and are marked in Australia by an overseas company. The project will assess the ability of a new subunit vaccine produced by recombinant DNA technology to 1) provide horses with high levels of protective immune responses and 2) to prevent or limit EHV-1 and EHV-4 infection following experimental challenge.Read moreRead less
Controlled Grafting of Polymer Surfaces for Biotechnology Applications. The aim of this project is to utilise novel polymerization methods to create highly functional polymer surfaces. We anticipate that the resultant structures will be useful for a number of applications including solid-phase organic synthesis and proteomics.